Evolent Health (EVH) Amortization of Deferred Charges (2017 - 2025)
Evolent Health (EVH) has 9 years of Amortization of Deferred Charges data on record, last reported at $2.1 million in Q4 2025.
- For Q4 2025, Amortization of Deferred Charges rose 134.11% year-over-year to $2.1 million; the TTM value through Dec 2025 reached $7.8 million, up 120.02%, while the annual FY2025 figure was $7.8 million, 120.02% up from the prior year.
- Amortization of Deferred Charges reached $2.1 million in Q4 2025 per EVH's latest filing, down from $3.3 million in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $11.7 million in Q1 2022 and bottomed at -$10.6 million in Q2 2022.
- Average Amortization of Deferred Charges over 5 years is $1.5 million, with a median of $1.0 million recorded in 2023.
- Peak YoY movement for Amortization of Deferred Charges: crashed 504.1% in 2023, then soared 897.28% in 2025.
- A 5-year view of Amortization of Deferred Charges shows it stood at $3.1 million in 2021, then crashed by 82.65% to $540000.0 in 2022, then skyrocketed by 66.67% to $900000.0 in 2023, then dropped by 0.33% to $897000.0 in 2024, then surged by 134.11% to $2.1 million in 2025.
- Per Business Quant database, its latest 3 readings for Amortization of Deferred Charges were $2.1 million in Q4 2025, $3.3 million in Q3 2025, and $1.2 million in Q2 2025.